
Ipilimumab active in advanced melanoma with brain mets
(HealthDay) -- For some patients with advanced melanoma and brain metastases, ipilimumab is active, according to the results of a phase 2 study published online March 27 in The Lancet Oncology.
Mar 27, 2012
0
0